Objective:

To explore recent innovations and challenges in small molecule development, particularly in oral dosage forms.

Approach:

• API Stability: Examines stress testing and predictive tools to anticipate degradation pathways and improve formulation decisions.
• Softgel Evolution: Discusses the development of phthalate-free softgels using glycerin and sorbitol, along with challenges in managing formulation changes in Europe.
• Nitrosamine Testing: Features insights from industry experts on ultra-trace detection, API-excipient interactions, and evolving risk assessment expectations.

Key Findings:

• Stress testing and predictive tools can enhance API stability and formulation robustness.
• Phthalate-free softgel formulations are being developed to meet changing regulatory demands.
• Industry experts are addressing challenges in nitrosamine testing and risk assessment.

Interpretation:

The eBook compiles various articles that specifically address innovations in oral dosage forms, API stability, nitrosamine testing, and regulatory challenges in small molecule development.

Limitations:

• The article does not provide specific data or case studies to support the discussed innovations.
• No quantitative analysis of the impact of these innovations on small molecule development is presented.

Conclusion:

The collection provides a comprehensive overview of current trends and challenges in small molecule formulation and development.